TerrAscend (TSNDF) Income from Non-Controlling Interests (2021 - 2026)

TerrAscend (TSNDF) reported Income from Non-Controlling Interests of $1.1 million for Q1 2026, down 18.89% year-over-year from $1.3 million in Q1 2025, and down 5.04% quarter-over-quarter from $1.1 million in Q4 2025.

TerrAscend (TSNDF) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Income from Non-Controlling Interests data on file, last reported at $1.1 million in Q1 2026.

  • Income from Non-Controlling Interests for Q1 2026 came in at $1.1 million, down 18.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 million (down 30.17% YoY), and the FY2025 annual result was $4.9 million, down 35.24% from the prior year.
  • Income from Non-Controlling Interests retreated to $1.1 million in Q1 2026 per TSNDF's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $2.3 million in Q4 2023 and troughed at $351000.0 in Q1 2022.
  • A 5-year average of $1.6 million and a median of $1.7 million in 2024 frame the typical range for Income from Non-Controlling Interests.
  • The sharpest annual moves came in 2023 and 2025: Income from Non-Controlling Interests surged 522.79% in 2023, then slumped 40.93% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $1.0 million in 2022, then jumped by 124.66% to $2.3 million in 2023, then dropped by 27.42% to $1.7 million in 2024, then sank by 34.05% to $1.1 million in 2025, then slipped by 5.04% to $1.1 million in 2026.
  • Business Quant data shows TSNDF's Income from Non-Controlling Interests at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 TerrAscend - - 34.60 Mn 1.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.06 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 1.69 Mn
Sep 30, 2024 1.73 Mn
Jun 30, 2024 1.94 Mn
Mar 31, 2024 2.20 Mn
Dec 31, 2023 2.32 Mn
Sep 30, 2023 2.16 Mn
Jun 30, 2023 2.14 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 2.23 Mn
Jun 30, 2022 945,000.00
Mar 31, 2022 351,000.00
Dec 31, 2021 556,000.00
Sep 30, 2021 1.41 Mn
Jun 30, 2021 998,000.00